Cerevel Therapeutics Company
Cerevel Therapeutics is a biopharmaceutical company.
Industry:
NeuroTech
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2018-10-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
19
Total Funding:
1145000000
Last Funding Date:
2021
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership